Mark For: ZYLA™ trademark registration is intended to cover the categories of
Research |
![]() ![]() ![]() ![]() ![]() |
Serial Number | 88418492 |
Mark Literal Elements | ZYLA |
Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
Mark Type | TRADEMARK. SERVICE MARK |
Register | PRINCIPAL |
Current Location | PETITIONS OFFICE 2020-04-09 |
Basis | 1(b) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | No |
Intent To Use | Yes |
Filed ITU | Yes |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | Keith Barritt |
Attorney Docket Number | 480150009001 |
Law Office Assigned | L90 |
Employee Name | LATTUCA, FRANK J |
2019-05-07 | Application Filed |
2019-09-05 | Location: PUBLICATION AND ISSUE SECTION |
2019-10-08 | Published |
2019-10-08 | Published for Opposition |
2019-10-08 | Status: Live/Pending |
2019-10-25 | Transaction Date |
2019-11-07 | Status: A request for an extension of time to file an opposition has been filed with the Trademark Trial and Appeal Board. For further i |
2020-04-09 | Location: PETITIONS OFFICE |
Party: | ![]() |
Address | 600 LEE ROAD SUITE 100 WAYNE, PENNSYLVANIA UNITED STATES 19087 |
Legal Entity Type | Corporation |
Legal Entity State | DELAWARE |
![]() | IMAGE/JPEG | 2019-05-07 |
![]() | MULTI | 2019-05-07 |
![]() | XML | 2019-07-23 |
![]() | APPLICATION/XML | 2019-07-23 |
![]() | APPLICATION/XML | 2019-08-28 |
![]() | MULTI | 2019-08-29 |
![]() | MULTI | 2019-09-03 |
![]() | XML | 2019-09-18 |
![]() | XML | 2019-09-18 |
![]() | XML | 2019-10-08 |
![]() | XML | 2020-03-05 |
![]() | MULTI | 2020-04-10 |
IC 005. US 006 018 044 046 051 052. G & S: pharmaceutical preparations for the treatment, prevention and management of central nervous system disorders and diseases; pharmaceutical preparations for the treatment of pain and pain associated with inflammation; pharmaceutical preparations for the treatment of migraine; and pharmaceutical preparations for the treatment of inflammatory disorders and diseases, none of the foregoing goods for use as a central nervous system depressant or for the treatment of cataplexy or sleep disorders
IC 035. US 100 101 102. G & S: wholesale and retail store services featuring medicines for human and veterinary use
IC 042. US 100 101. G & S: consulting services in the field of pharmaceutical research and development; and providing medical and scientific research information in the field of pharmaceuticals
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
International Codes: | 35 |
U.S. Codes: | 100,101,102 |
International Codes: | 42 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
GS0051 | pharmaceutical preparations for the treatment, prevention and management of central nervous system disorders and diseases; pharmaceutical preparations for the treatment of pain and pain associated with inflammation; pharmaceutical preparations for the treatment of migraine; and pharmaceutical preparations for the treatment of inflammatory disorders and diseases |
Description | Date | Proceeding Number |
---|---|---|
CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED | 2020-04-09 | 86882 |
ASSIGNED TO PETITION STAFF | 2020-04-08 | 86882 |
TEAS POST PUBLICATION AMENDMENT RECEIVED | 2020-03-05 | 1111 |
EXTENSION OF TIME TO OPPOSE RECEIVED | 2019-11-07 | |
PUBLISHED FOR OPPOSITION | 2019-10-08 | |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2019-10-08 | |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2019-09-18 | |
ASSIGNED TO LIE | 2019-09-05 | 70138 |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2019-09-02 | |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-08-28 | 88889 |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2019-08-28 | |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-08-28 | 88889 |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2019-07-23 | 6325 |
NON-FINAL ACTION WRITTEN | 2019-07-23 | 82430 |
NON-FINAL ACTION E-MAILED | 2019-07-23 | 6325 |
ASSIGNED TO EXAMINER | 2019-07-22 | 82430 |
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | 2019-06-26 | |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2019-05-22 | |
NEW APPLICATION ENTERED IN TRAM | 2019-05-10 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.